For the first time, Yale University scientists have synthesized a chemical compound, leading to the development of a new class of molecules that may target and destroy cancer stem cells.
Novel Anti-Cancer Agents Possible Via Antibiotic
An antibiotic known for its immunosuppressive functions could also point the way to the development of new anti-cancer agents, researchers at the Indiana University School of Medicine have reported.
An antibiotic known for its immunosuppressive functions could also point the way to the development of new anti-cancer agents, researchers at the Indiana University School of Medicine have reported.
The scientists are particularly excited about lomaiviticin aglycon's potential to kill ovarian cancer stem cells because the disease is notoriously resistant to Taxol and Carboplatin, two of the most common chemotherapy drugs.
"Ovarian cancer has a high rate of recurrence, and after using chemotherapy to fight the tumor the first time, you're left with resistant tumor cells that tend to keep coming back. If you can kill the stem cells before they have the chance to form a tumor, the patient will have a much better chance of survival - and there aren't many potential therapies out there that target cancer stem cells right now," explained Mor.
Immunosuppressives Could Become Anti-Cancer Agents
Immunosuppressives seem to hold exciting promise in cancer treatment. One particular antibiotic could become an anti-cancer agent too, it is hoped.
Immunosuppressives seem to hold exciting promise in cancer treatment. One particular antibiotic could become an anti-cancer agent too, it is hoped.
Source-ANI
Sprite Can Enhance Effect Of Oral Anti-cancer Drug
Sprite, the popular lemon-lime flavored, caffeine-free soft drink, can enhance the effectiveness of an oral anticancer drug.
Sprite, the popular lemon-lime flavored, caffeine-free soft drink, can enhance the effectiveness of an oral anticancer drug.
Excess of Protein Used as Anti-cancer Drug Triggers Parkinson's Disease
A new study has found that over-activation of a single protein may shut down the brain-protecting effects of a molecule and increases the likeliness of the most common form
A new study has found that over-activation of a single protein may shut down the brain-protecting effects of a molecule and increases the likeliness of the most common form
